Sangamo Therapeutics
SGMO
SGMO
197 hedge funds and large institutions have $911M invested in Sangamo Therapeutics in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 74 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
20% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 74
22% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 23
Holders
197
Holding in Top 10
–
Calls
$16.9M
Puts
$11M
Top Buyers
| 1 | +$6.3M | |
| 2 | +$5.06M | |
| 3 | +$4.29M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.2M |
| 5 |
Morgan Stanley
New York
|
+$2.12M |
Top Sellers
| 1 | -$10.2M | |
| 2 | -$8.52M | |
| 3 | -$6.57M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.57M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$5.38M |